Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideBMYBristol Myers Squibb
FinDog View：Bullish
TMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | BMY | TMO |
|---|
| Close | 62.48 | 697.00 |
| Market Cap | $128B | $258B |
| 1M | +0.13% | +3.25% |
| P/E (TTM) | 13.8 | 36.4 |
| Forward P/E | 9.3 | 24.6 |
| P/E 5-Yr Percentile | 27 | 78 |
| P/S | 2.6 | 5.4 |
| P/B | 5.7 | 4.7 |
| Dividend Yield | 4.58% | 0.29% |
| Latest Quarter Revenue | $13.1B | $12.1B |
| Revenue YoY | +6.9% | +9.1% |
| Gross Margin | 68.3% | — |
| Latest Quarter EPS | 1.05 | 4.64 |
| Avg Post-Earnings Move | ±2.2% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 3.98% | 1.82% |
| 90-Day Net Insider Buying | −$0.44M | −$40.3M |
BMY · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
